Lipicard Technologies Limited - Product Pipeline Review - 2016 - Global Markets Direct - Market Research

Lipicard Technologies Limited - Product Pipeline Review - 2016

Lipicard Technologies Limited - Product Pipeline Review - 2016 - Global Markets Direct - Market Research
Lipicard Technologies Limited - Product Pipeline Review - 2016
Published Jul 30, 2016
58 pages — Published Jul 30, 2016
Price US$ 1,500.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Global Markets Directs, Lipicard Technologies Limited - Product Pipeline Review - 2016, provides an overview of the Lipicard Technologies Limiteds pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Lipicard Technologies Limited, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of Lipicard Technologies Limited
- The report provides overview of Lipicard Technologies Limited including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Lipicard Technologies Limiteds pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Lipicard Technologies Limiteds out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate Lipicard Technologies Limiteds strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Lipicard Technologies Limited
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Lipicard Technologies Limiteds pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potenti

  
Source:
Document ID
GMDHC08105CDB
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents25
  List of Tables61
  List of Figures61
Lipicard Technologies Limited Snapshot71
  Lipicard Technologies Limited Overview71
  Key Information71
  Key Facts71
Lipicard Technologies Limited Research and Development Overview83
  Key Therapeutic Areas83
Lipicard Technologies Limited Pipeline Review112
  Pipeline Products by Stage of Development111
  Pipeline Products Monotherapy121
Lipicard Technologies Limited Pipeline Products Glance133
  Lipicard Technologies Limited Early Stage Pipeline Products131
    Preclinical Products/Combination Treatment Modalities132
    Discovery Products/Combination Treatment Modalities151
Lipicard Technologies Limited Drug Profiles1636
  gabafol161
    Product Description161
    Mechanism of Action161
    R&D Progress161
  KeraKlear171
    Product Description171
    Mechanism of Action171
    R&D Progress171
  LT-1121181
    Product Description181
    Mechanism of Action181
    R&D Progress181
  LT-1123191
    Product Description191
    Mechanism of Action191
    R&D Progress191
  LT-2121201
    Product Description201
    Mechanism of Action201
    R&D Progress201
  LT-2221211
    Product Description211
    Mechanism of Action211
    R&D Progress211
  LT-2223221
    Product Description221
    Mechanism of Action221
    R&D Progress221
  LT-2321231
    Product Description231
    Mechanism of Action231
    R&D Progress231
  LT-2322241
    Product Description241
    Mechanism of Action241
    R&D Progress241
  LT-2323251
    Product Description251
    Mechanism of Action251
    R&D Progress251
  LT-2421261
    Product Description261
    Mechanism of Action261
    R&D Progress261
  LT-2423271
    Product Description271
    Mechanism of Action271
    R&D Progress271
  LT-2521281
    Product Description281
    Mechanism of Action281
    R&D Progress281
  LT-3121291
    Product Description291
    Mechanism of Action291
    R&D Progress291
  LT-3122301
    Product Description301
    Mechanism of Action301
    R&D Progress301
  LT-4121311
    Product Description311
    Mechanism of Action311
    R&D Progress311
  LT-4122321
    Product Description321
    Mechanism of Action321
    R&D Progress321
  LT-4123331
    Product Description331
    Mechanism of Action331
    R&D Progress331
  LT-4124341
    Product Description341
    Mechanism of Action341
    R&D Progress341
  LT-4125351
    Product Description351
    Mechanism of Action351
    R&D Progress351
  LT-4126361
    Product Description361
    Mechanism of Action361
    R&D Progress361
  LT-5121371
    Product Description371
    Mechanism of Action371
    R&D Progress371
  LT-5122381
    Product Description381
    Mechanism of Action381
    R&D Progress381
  LT-5221391
    Product Description391
    Mechanism of Action391
    R&D Progress391
  LT-5222401
    Product Description401
    Mechanism of Action401
    R&D Progress401
  LT-5223411
    Product Description411
    Mechanism of Action411
    R&D Progress411
  LT-5321421
    Product Description421
    Mechanism of Action421
    R&D Progress421
  LT-5322431
    Product Description431
    Mechanism of Action431
    R&D Progress431
  LT-5323441
    Product Description441
    Mechanism of Action441
    R&D Progress441
  LT-5421451
    Product Description451
    Mechanism of Action451
    R&D Progress451
  LT-5423461
    Product Description461
    Mechanism of Action461
    R&D Progress461
  LT 5521471
    Product Description471
    Mechanism of Action471
    R&D Progress471
  peroxibrate481
    Product Description481
    Mechanism of Action481
    R&D Progress481
  platrol491
    Product Description491
    Mechanism of Action491
    R&D Progress491
  raviprofen501
    Product Description501
    Mechanism of Action501
    R&D Progress501
  LT-6121511
    Product Description511
    Mechanism of Action511
    R&D Progress511
Lipicard Technologies Limited Pipeline Analysis524
  Lipicard Technologies Limited Pipeline Products by Target521
  Lipicard Technologies Limited Pipeline Products by Route of Administration531
  Lipicard Technologies Limited Pipeline Products by Molecule Type541
  Lipicard Technologies Limited Pipeline Products by Mechanism of Action551
Lipicard Technologies Limited Locations And Subsidiaries561
  Head Office561
Appendix572
  Methodology571
  Coverage571
  Secondary Research571
  Primary Research571
  Expert Panel Validation571
  Contact Us571
  Disclaimer581

Table Of Contents

Global Markets Direct - Market Research—Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information.

About the Author


Cite this Report

  
MLA:
Global Markets Direct - Market Research. "Lipicard Technologies Limited - Product Pipeline Review - 2016" Jul 30, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/Global-Markets-Direct-Market-Research/Lipicard-Technologies-Limited-Product-Pipeline-Review-2016-2088-16314>
  
APA:
Global Markets Direct - Market Research. (2016). Lipicard Technologies Limited - Product Pipeline Review - 2016 Jul 30, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/Global-Markets-Direct-Market-Research/Lipicard-Technologies-Limited-Product-Pipeline-Review-2016-2088-16314>
  
US$ 1,500.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.